A plethora of apoptotic stimuli converge on the mitochondria and affect their membrane integrity. As a consequence, multiple death-promoting factors residing in the mitochondrial intermembrane space are liberated in the cytosol. Pro-and antiapoptotic Bcl-2 family proteins control the release of these mitochondrial proteins by inducing or preventing permeabilization of the outer mitochondrial membrane. Once released into the cytosol, these mitochondrial proteins activate both caspase-dependent and -independent cell death pathways. Cytochrome c was the first protein shown to be released from the mitochondria into the cytosol, where it induces apoptosome formation. Other released mitochondrial proteins include apoptosis-inducing factor (AIF) and endonuclease G, both of which contribute to apoptotic nuclear DNA damage in a caspase-independent way. Other examples are Smac/DIABLO (second mitochondria-derived activator of caspase/direct IAP-binding protein with low PI) and the serine protease HtrA2/OMI (high-temperature requirement protein A2), which both promote caspase activation and instigate caspase-independent cytotoxicity. The precise mode of action and importance of cytochrome c in apoptosis in mammalian cells has become clear through biochemical, structural and genetic studies. More recently identified factors, for example HtrA2/OMI and Smac/DIABLO, are still being studied intensively in order to delineate their functions in apoptosis. A better understanding of these functions may help to develop new strategies to treat cancer.
Introduction
Mitochondria are present in almost all eukaryotic species. Present day eukaryotes lacking mitochondria, such as Entamoeba histolytica, may have lost these organelles in the course of their evolutionary deviation from the main eukaryotic lineage (Clark and Roger, 1995) . Others, like the anaerobic protozoan parasite Trichomonas vaginalis, comprise hydrogenosomes, subcellular compartments where ATP is generated concomitant with the reduction of protons to molecular hydrogen (Hackstein et al., 1999) . Mitochondria are considered remnants of invasive or symbiotic bacteria that predated or inhabited the 'pre-eukaryotic' cell (Lang et al., 1999) . Shielded from the cytoplasm by an inner and an outer membrane, mitochondria provide the eukaryotic cell with energy in the form of ATP that they produce by a process called oxidative phosphorylation (Tyler, 1992) . The cell obtains ATP, which is produced at the matrix side of the inner mitochondrial membrane (IMM), through pores present at the contact sites between the outer and the IMMs. The core components of this transmembrane pore are the voltage-dependent anion channel (VDAC), located in the outer mitochondrial membrane (OMM) and the adenine nucleotide transporter (ANT), present in the IMM. Besides being guardians of survival, mitochondria also harbour noxious molecules in the intermembrane space (IMS). These death-inducing proteins, although encoded in the nucleus of eukaryotic cells, often have distant relatives in the prokaryotic world (Frade and Michaelidis, 1997; Koonin and Aravind, 2002) .
The observation that the mitochondrial life-supporting ATP production is disturbed in cell death had already been reported in the 1950s by studying the consequences of X-ray irradiation of the mouse spleen, and this finding was corroborated in many other examples of cell death (Ashwell, 1952; Kroemer and Reed, 2000) . In fact, most proapoptotic signalling pathways, including those induced by DNA damage, growth factor depletion and cytosolic calcium overload, were found to converge on the mitochondria. A wide variety of apoptotic signals activate proapoptotic Bcl-2 members such as Bax, Bak and Bid, resulting in a disturbed balance between pro-and antiapoptotic Bcl-2 family proteins. As a consequence, OMM integrity is lost due to the oligomerization of proapoptotic Bcl-2 members in the OMM (Kuwana et al., 2002) or the formation of a megapore complex composed of VDAC and ANT (Marzo et al., 1998) . This results in the permeabilization of the OMM and the release of proteins from the IMS. Some of these proteins have cytotoxic activities due to caspase-dependent and -independent processes (Figure 1 ). These deadly proteins are the focus of this review.
First, we describe cytochrome c, the first mitochondrial protein shown to be released from mitochondria under apoptotic conditions. Cytochrome c sparks a caspase cascade by promoting apoptosome formation provided that apoptotic protease-activating factor-1 (Apaf-1) is expressed. Next, we focus on endonuclease G and apoptosis-inducing factor (AIF), both of which contribute to nuclear DNA degradation. Their contribution to apoptotic DNA damage is discussed in the context of the existence of other nonmitochondrial nucleases that are active in the course of apoptotic cell demise. Apart from cytochrome c, other mitochondrial factors such as Smac/DIABLO and HtrA2/OMI Figure 1 Multiple IMS proteins are released when the intrinsic apoptotic pathway is activated. OMM integrity is mainly controlled by the Bcl-2 family proteins. BH-3-only proteins become active by different stress conditions. Bid for example is cleaved by a number of proteases including caspase-8, granzyme B and cathepsin B into tBid, which counteracts antiapoptotic Bcl-2 proteins and may directly activate Bax. Other BH-3-only proteins indirectly activate Bax by blocking antiapoptotic Bcl-2. Cytosolic cytochrome c (cyt c) will trigger apoptosome formation ensuing in a caspase cascade. Multiple cellular substrates are targeted by caspases, including ICAD that becomes inactivated by cleavage, thereby liberating CAD, which will translocate to the nucleus and start oligonucleosomal DNA fragmentation. IAPs prevent caspase-9 dimerization and block active caspase-3 and -7. Smac/DIABLO (Smac) and HtrA2/OMI (Omi) neutralize IAP inhibition by binding to the BIR2 and BIR3 domains. Dimeric Smac/DIABLO tethers BIR1 and BIR2, whereas HtrA2/ OMI preferentially binds BIR2 of XIAP. In addition, Omi can cleave IAPs through its serine protease activity. Smac is subject to proteasome-mediated degradation, as it is targeted by the ubiquitin-protein ligase activity residing in the C-terminal RING domain of XIAP and cIAP1 and cIAP2. Smac and Omi may also start a caspase-independent cell death pathway (not depicted). AIF and endonuclease G (endo G) translocate from the mitochondria to the nucleus, where they degrade nuclear DNA in a caspaseindependent way Mitochondrial killer proteins X Saelens et al may also contribute to caspase activation, be it indirectly. Smac/DIABLO and HtrA2/OMI antagonize inhibitor of apoptosis proteins (IAPs), a family of cellular caspase inhibitors. However, Smac and HtrA2/ OMI also provoke caspase-independent cell death through as yet unknown mechanisms.
Cytochrome c
Cytochrome c is an evolutionarily conserved watersoluble protein that resides in the IMS. Cytochrome c is an essential component of the respiratory chain, an ATP-generating system that operates in the IMM through a series of multiprotein complexes (complexes I-V). In the respiratory chain, the potential energy of electrons derived from food metabolites such as malate and succinate is used to generate a proton gradient across the IMM. This results in the formation of a proton concentration gradient (protons are pumped to the outside of the IMM) and an electric potential (Dc m ) across the IMM. The F0F1-ATP synthase complex (complex V) utilizes this energy potential to convert ADP into ATP concurrent with proton flow back into the matrix. Cytochrome c participates in the electron transport chain by passing electrons from complex III to complex IV. In most apoptotic conditions, the OMM becomes permeable, resulting in the leakage of cytochrome c into the cytosol by a process controlled by Bcl-2 family members (Kluck et al., 1997; Yang et al., 1997; Cory and Adams, 2002) . What are the consequences of cytochrome c loss in apoptosis for the maintenance of mitochondrial respiration and membrane potential? Most likely these are minor early after OMM permeabilization, because cytochrome c is present in a large excess in the mitochondrial IMS, at a concentration of 0.5 to 5 mM (Forman and Azzi, 1997) . Even after its total diffusion into the cytosol, the concentration of cytochrome c remains approximately 10 mM in HeLa cells (Waterhouse et al., 2001) , a concentration that can fully support ATP production and c m (Mootha et al., 2001; Waterhouse et al., 2001) . Furthermore, cytochrome c is present in two compartments in the mitochondria: the space between the inner and OMM on the one hand, and the cristae on the other. The majority of oxidative phosphorylation takes place in the cristae, which are separated from the IMS by narrow tubular junctions (Frank et al., 2002) . Accordingly, the compartment between IMM and OMM contains 15% of the total cytochrome c, while the cristae contain about 85% (Bernardi and Azzone, 1981) . OMM permeabilization allows the diffusion of cytochrome c from the former compartment. However, the cytochrome c pool residing in the cristae requires more drastic remodelling of the mitochondrial structure, which eventually occurs in the course of mitochondrial damage, leading to the loss of Dc m (Scorrano et al., 2002) . In certain cases, caspase activity instigated by cytosolic cytochrome c (see below) contributes to this Dc m drop, as was shown by the use of synthetic caspase inhibitors and Apaf1 À/À cells (Waterhouse et al., 2001 ). In addition, caspase activity further damages the function of permeabilized mitochondria by affecting the activity of complexes I and II, inevitably leading to the loss of Dc m and the generation of reactive oxygen species . Sustained cytochrome c release, even in the presence of caspase inhibitors, will eventually lead to Dc m loss, as was shown in nerve growth factor-deprived sympathetic neurons (Deshmukh et al., 2000) . In conclusion, the loss of cytochrome c per se as a consequence of OMM permeabilization most likely does not lead to dysfunction of the electron transport chain and dissipation of Dc m . Rather, secondary events resulting from cytosolic changes, caused by the release of cytochrome c and other mitochondrial IMS proteins, feed back on permeabilized mitochondria and affect their function. Cytochrome c was identified as a factor that is crucial for the activation of caspase-3 in a cell-free system, and was therefore initially named Apaf-2 by Xiaodong Wang (Liu et al., 1996) . Microinjection of cytochrome c into the cytosol leads to apoptosis (Li et al., 1997; Zhivotovsky et al., 1998) . Mammalian holocytochrome c, that is cytochrome c with its prosthetic haem group attached as it is found in the IMS, can induce caspase-3 activation in cell-free extracts by triggering the assembly of the apoptosome, a high molecular weight caspaseactivating complex (Cain et al., 2000) . Apoptosome formation is caused by the binding of cytochrome c to the C-terminal region of Apaf-1, a cytosolic protein with an N-terminal caspase-recruitment domain (CARD), a nucleotide-binding domain with homology to Caenorhabditis elegans CED-4, and a C-terminal domain containing 12-13 WD-40 repeats . Binding of cytochrome c to Apaf-1 is mediated by the WD-40 repeats. Binding of cytochrome c facilitates the association of dATP with Apaf-1 and exposes the Nterminal CARD, which can now oligomerize and become a platform on which the initiator caspase-9 is recruited and activated through a CARD-CARD interaction (Adrain et al., 1999; Jiang and Wang, 2000) . Apaf-1 devoid of its tail of WD-40 repeats is constitutively active and highly toxic, indicating that the WD-40 repeats region functions as an intramolecular inhibitor (Hu et al., 1998; Srinivasula et al., 1998) . The activation of caspase-9 depends solely on the CARDmediated dimerization and not on its proteolytic processing Renatus et al., 2001; Boatright et al., 2003; Shiozaki et al., 2003) . Exposure of the CARD as a result of Apaf-1 association with cytochrome c and dATP presumably shifts the equilibrium of cytosolic procaspase-9 monomers towards assembly into dimers. Consecutively, caspase-3 is recruited to the apoptosome, where it is activated by the resident caspase-9, which in turn may process itself or become proteolysed by caspase-3 (Bratton et al., 2001) . The three-dimensional structure of the apoptosome assembled from recombinant Apaf-1, procaspase-9, cytochrome c and dATP has recently been determined by electron cryomicroscopy. The apoptosome has a wheel-like structure with sevenfold symmetry. This heptameric structure with hub and spokes forms the metaphoric wheel of death. The CARD domains are exposed in the centre of the wheel and act as a docking region for the recruitment of procaspase-9 (Acehan et al., 2002) .
The importance of cytochrome c, Apaf-1 and caspase-9 for the execution of intrinsic apoptosis in mammals has been confirmed by targeted disruption of the corresponding genes. All three knockout mice exhibit embryonic lethality or die soon after birth, indicating the importance of the apoptosome components in mammalian development. Apaf-1 À/À and caspase-9 À/À mice display brain malformation due to impaired neuronal apoptosis (Cecconi et al., 1998; Hakem et al., 1998; Kuida et al., 1998) . Cytochrome c À/À mice die in utero by midgestation . Despite their severe phenotype and developmental delay, cytochrome c À/À embryos seem capable of developing differentiated tissues derived from the three germ layers, indicating that cytochrome c, unlike AIF (see below), is not essential for cavitation during early embryogenesis Joza et al., 2001) . Cytochrome c À/À embryonic cells demonstrate defects in response to UV irradiation, staurosporine treatment and growth factor depletion, but remain sensitive to TNF treatment. In view of the essential functions of cytochrome c in both oxidative phosphorylation and the intrinsic apoptotic pathway, it is impossible to pinpoint the molecular mechanism responsible for the phenotype of mouse embryos lacking cytochrome c. By swapping critical amino-acid residues between yeast and horse cytochrome c, Abdullaev et al. (2002) generated a cytochrome c mutein that lacks apoptogenic properties, but has electron transfer and antioxidant activity. A targeted knock-in of this or a similar variant of cytochrome c would allow the evaluation of the contribution of cytochrome c to apoptosis without affecting its function in oxidative phosphorylation.
In the mouse, the phenotypes resulting from the targeted disruption of Apaf-1 and caspase-9 seem to indicate an important function for the apoptosome in neuronal development and cellular stresses that converge on the mitochondria. However, a small percentage of the Apaf-1 À/À animals reach adulthood and develop almost normally (Honarpour et al., 2000) . This indicates that in most mammalian tissues, alternative cell death mechanisms exist that can substitute for the lack of apoptosome formation. Indeed, the loss of interdigital cells in the mouse embryo, a classic example of developmental apoptosis, is not prevented in the absence of Apaf-1 or when caspases are blocked, but proceeds through a necrotic pathway (Chautan et al., 1999) . In addition, in an elegant setting that allows the in vivo reconstitution of the haematopoietic system from foetal liver stem cells, Andreas Strasser and his team showed that neither Apaf-1 nor caspase-9 deficiency affected the differentiation, homeostasis and apoptotic responses of lymphocytes (Marsden et al., 2002) . As the Bcl-2 family has a major role in haematopoietic homeostasis and regulates the release of mitochondrial IMS proteins, these findings indicate that apoptosome formation induced by cytosolic cytochrome c probably serves merely as an amplifier of caspase activity. Nevertheless, this amplification seems required for neuronal development and may determine the response of cancer cells to treatment.
Although cytochrome c release in response to stress has been reported in organisms as diverse as yeast and plants, cytochrome c-dependent activation of caspases is restricted to vertebrates. Saccharomyces cerevisiae and Arabidopsis thaliana lack a functional orthologue of Apaf-1, and C. elegans CED-4 does not contain a WD-40 repeats domain that is used by cytochrome c to activate Apaf-1. The role of Drosophila melanogaster cytochrome c in caspase activation is less clear. First, in a vertebrate cell-free extract, Drosophila cytochrome c can induce caspase activation, be it less efficiently than mammalian cytochrome c (Kluck et al., 2000) . Second, DARK, the fly Apaf-1 orthologue, contains a WD-40 repeats region through which it can bind cytochrome c (Rodriguez et al., 1999) . Finally, the loss of DARK function leads to hyperplasia of the central nervous system, reminiscent of the Apaf-1 phenotype (Kanuka et al., 1999; Rodriguez et al., 1999) . It is possible that in the fly an apoptosome-like complex containing the caspase-9 orthologue DRONC is formed in the vicinity of the mitochondrial membrane, which may be activated by disturbance of mitochondrial integrity (Dorstyn et al., 2002) .
Mitochondrial mediators of nuclear chromatin condensation and DNA fragmentation
Apoptosis is characterized by chromatin condensation and both high molecular weight and internucleosomal DNA fragmentation. Several nucleases, one helicase and even an oxidoreductase are implicated in apoptotic nuclear DNA degradation, a process regulated by caspase-dependent and -independent mechanisms. Caspase-activated DNase (CAD), also named DNA fragmentation factor 40 (DFF40), is part of a cytosolic heterodimer. Its caspase-dependent mode of activation and physiological relevance has been characterized extensively, including by making use of CAD À/À mice. Caspase-3 and -7 activate CAD by cleaving its inhibitor and chaperone ICAD or DFF45. This allows translocation of CAD to the nucleus, where it generates oligonucleosomal DNA fragments Sakahira et al., 1998) . Caspase-3 also activates ACINUS (apoptotic chromatin condensation inducer in the nucleus), leading to chromatin condensation. HELI-CARD is a cytosolic helicase that contains a CARD domain, and is cleaved by caspases. Cleavage of HELICARD allows the CARD-free helicase domain to translocate to the nucleus, where it accelerates DNA degradation (Sahara et al., 1999; Kovacsovics et al., 2002) . Taken together, CAD, ACINUS and HELI-CARD act downstream of caspases to reshape the chromatin in the apoptotic cell. Two mitochondrial factors also contribute to nuclear chromatin condensa-tion and fragmentation: endonuclease G and AIF. In apoptotic conditions associated with OMM permeabilization, both proteins are released, translocate to the nucleus and affect chromatin in a caspase-independent way.
Endonuclease G
Endonuclease G is encoded by a nuclear gene and translated into a 33 kDa precursor protein containing an N-terminal mitochondrial targeting sequence of 48 amino-acid residues, which is removed upon import into the mitochondria. Endonuclease G was identified by mass spectrometry in the supernatant fraction of tBid-treated mouse liver mitochondria, as a protein that induces caspase-independent DNA fragmentation in purified HeLa nuclei . Although Wang and co-workers observed nuclear DNA laddering by endonuclease G, we were unable to demonstrate clear internucleosomal DNA fragmentation using supernatant from tBid-treated mitochondria (van Loo et al., 2001) . It is likely that, under physiological conditions, endonuclease G cooperates with exonucleases and DNase I to generate internucleosomal DNA fragments (Widlak et al., 2001 ). Endonuclease G is evolutionarily conserved, with orthologues known in bacteria and fungi but, so far, not in plants. CPS-6 (ced-3 protease suppressor 6), the C. elegans endonuclease G orthologue, is also localized in the mitochondria. In cps-6 mutant nematodes, DNA degradation is impaired and cell death is delayed, indicating an important role for DNA degradation in apoptosis in vivo (Parrish et al., 2001) . Worm AIF homologue (WAH-1, see below) interacts and cooperates with CPS-6 to promote DNA degradation in C. elegans . Recently, the C. elegans nuclease CRN-1 (cell death-related nuclease) was identified as another nuclear factor that associates and cooperates with CPS-6 to degrade nuclear DNA . CRN-1 was discovered using a candidate-based functional genomic analysis (alterations in TdTmediated dUTP-biotin nick end labelling staining 'TUNEL') making use of an RNA-interference (RNAi)-based approach, the available genome sequence of C. elegans and the recognition of canonical nuclease motifs using bioinformatics (Parrish et al., 2003) . Remarkably, CRN-1 is an orthologue of the mammalian flap endonuclease-1 involved in DNA replication and repair. Thus, like cytochrome c and HtrA2/OMI (see below), CRN-1 represents another example of a cellular protein that is able to change from an important housekeeping component into a cell death executioner.
To what extent does endonuclease G contribute to apoptotic nuclear DNA degradation? In multicellular organisms apoptosis is normally associated with rapid removal of the dying cell by phagocytes. The nucleases discussed above act inside the dying cell. CAD-deficient cells, or cells derived from transgenic mice overexpressing a caspase-resistant ICAD form, show very limited or no DNA degradation upon exposure to proapoptotic stimuli such as TNF, Fas ligand and staurosporine. This indicates that CAD is the major contributor to internucleosomal DNA fragmentation inside the apoptotic cell (Zhang et al., 1998; McIlroy et al., 2000; Kawane et al., 2003) . Surprisingly, CAD À/À mice and transgenic mice overexpressing a caspase-resistant ICAD form develop normally and display a similar number of TUNEL-positive cells in their adult tissues as wild-type animals (McIlroy et al., 2000; Kawane et al., 2003) . Although in vitro cultured thymocytes from CAD-deficient mice lack DNA degradation in response to dexamethasone, Fas ligand or staurosporine treatment, nuclear DNA digestion of CAD deficient apoptotic thymocytes proceeds normally when they are phagocytosed by macrophages. Acid lysosomal DNase II residing in the endocytic pathway of the engulfing macrophage is essential for the degradation of apoptotic nuclear DNA, as evidenced by the study of DNase II À/À mice and macrophages (Kawane et al., 2003) . Taken together, these results show that endonuclease G is unable to complement CAD or DNase II deficiency in vitro in apoptotic cultured cells. In addition, it is difficult to envision an endonuclease G knock-in approach that would impede its nuclear DNase activity without affecting its putative function in mitochondrial DNA metabolism.
Apoptosis-inducing factor
Clear evidence for the existence of a mitochondrial factor that is able to induce nuclear apoptosis came from cell-free experiments, by the research group of Guido Kroemer, in which purified mitochondria were coincubated with nuclei isolated from HeLa cells (Zamzami et al., 1996) . By scoring the nuclear fraction for the appearance of chromatin condensation and large-scale DNA fragmentation, it was shown that permeability transition of mitochondria, for instance, induced by atractyloside treatment, could lead to nuclear apoptotic alterations. The same group demonstrated that this mitochondrial nucleolytic activity copurified with a 57 kDa protein, which they named AIF (Susin et al., 1999b) . AIF is a phylogenetically ancient flavoprotein with orthologues in archaebacteria, eubacteria, metazoa, fungi and plants. This remarkable conservation is a reflection of the NADH oxidase activity of AIF, allowing it to act as a free radical scavenger, thus, despite its name, protecting cells from cell death induced by oxidative stress (Miramar et al., 2001; Klein et al., 2002) . Indeed, the mouse harlequin (Hq) mutation, which is characterized by progressive degeneration of terminally differentiated cerebellar and retinal neurons, is attributed to a murine ecotropic leukaemia proviral insertion in the first intron of both AIF alleles. As a result, AIF expression is suppressed by 80% in the cerebellum and most other tissues. This correlates with increased catalase activity and lipid hydroperoxides in the cerebella of Hq mutant mice. Furthermore, the increased sensitivity to oxidative stress-induced cell death of Hq compared to wild-type primary granule cells could be restored by retroviral transduction with AIF (Klein et al., 2002) .
How AIF exerts its apoptogenic function is unclear, since it lacks intrinsic nuclease activity and its oxidoreductase activity is dispensable for its cytotoxicity (Miramar et al., 2001; Wang et al., 2002) . Nevertheless, functional deletion mapping studies and the resolution of the human AIF crystal structure allow pinpointing of the regions implicated in the death effector function of AIF (Ye et al., 2002; Gurbuxani et al., 2003) . The nuclear AIF gene is translated into a 67 kDa precursor protein with an N-terminal mitochondrial localization sequence (MLS) that is cleaved off after import into the mitochondria, giving rise to the mature 57 kDa protein. AIF contains two consensus nuclear localization sequences, of which the more C-terminal (residues 445-451) functionally predominates. Translocation of AIF from the cytosol, after its release from the mitochondria, into the nucleus is hampered by the interaction of heat-shock protein 70 with the N-terminal domain of mature AIF . Finally, deletion of the C-terminal part (residues 567-609) generates an AIF mutant lacking chromatincondensing activity (Gurbuxani et al., 2003) . The three-dimensional structure of AIF reveals a strong positive electrostatic potential at its surface, in line with the ability of AIF to interact with DNA. AIF mutants that fail to interact with DNA do not induce cell death (Ye et al., 2002) .
The release of the respective AIF homologues from the mitochondria and their translocation to the nucleus is conserved in Dictyostelium discoideum and the nematode C. elegans (Arnoult et al., 2001; Wang et al., 2002) . Of note, the downregulation of WAH-1 expression, the nematode orthologue of AIF, only delays nematode programmed cell death (PCD). Whether in mammals AIF interacts with and stimulates the activity of endonuclease G, as is the case for their C. elegans counterparts, is not clear.
The gene encoding AIF is named 'programmed cell death 8' and is located on the X chromosome in both man and mouse. AIF-homologous mitochondrion-associated inducer of cell death (AMID) and p53-responsive gene 3 (PRG3) are both related to AIF (Ohiro et al., 2002; Wu et al., 2002) . AMID is an AIF-homologous flavoprotein that is presumably associated with the OMM. Overexpression of AMID in 293T cells induces apoptotic cell death that could not be inhibited by Bcl-2, CrmA or zVAD-fmk. PRG3 localizes in the cytoplasm and its putative oxidoreductase activity is dispensable for its apoptotic function. The molecular mechanism of action of AMIDor PRG3-induced cell death is unclear.
Caspase-dependent release of caspase-independently acting AIF and endonuclease G?
Although the nuclear DNA degradation activity exerted or mediated by endonuclease G and AIF is caspase independent, their release from the mitochondria in some PCD conditions is not. In C. elegans, GFP-tagged WAH-1 release, induced by the expression of the BH3-only protein EGL-1, is much more efficient in a Ced-3 wild-type compared to a Ced-3 mutant background . The cytotoxic activity of transgenically expressed WAH-1 and CPS-6 in posterior lateral microtubule neurons is also more pronounced in wild-type compared to Ced-3-deficient animals. Thus, in the nematode, the release and the activity of WAH-1 and CPS-6 and apoptotic nuclear DNA degradation are more effective when the caspase CED-3 is present. Likewise, in isolated mitochondria derived from HeLa cells or mouse liver, recombinant Bax or tBid do not induce the release of AIF or endonuclease G, whereas cytochrome c, Smac/ DIABLO and HtrA2/OMI are readily detected in the mitochondrial supernatant (Arnoult et al., 2003) . In addition, in cells treated with proapoptotic drugs that result in the eventual loss of mitochondrial membrane potential, the broad range caspase-inhibitor zVAD-fmk or Apaf-1 deficiency prevent endonuclease G and AIF diffusion into the cytosol, whereas cytochrome c, Smac/DIABLO and HtrA2/OMI release were unaffected (Arnoult et al., 2003) . However, other reports demonstrated that AIF translocation to the nucleus could occur in the complete absence of caspase activity. In MEFs, for example, the activation of poly(ADPribose) polymerase-1 by DNA-alkylating agents leads to cell death that is independent of caspase activity, and leads to the early translocation of AIF from the mitochondria to the nucleus, whereas cytochrome c release is observed later (Yu et al., 2002) . In addition, the commitment phase to apoptosis of activated T cells following anti-CD2 treatment or treatment with a low concentration of staurosporine is characterized by mitochondrial release of AIF, occurring before the release of cytochrome c (Dumont et al., 2000) . Which mechanism is responsible for the selective early release of AIF in certain settings or how caspases bring about the release of AIF and endonuclease G from mitochondria in other apoptotic conditions is a conundrum. However, one cannot exclude that differences in the sensitivities of the detection methods may explain the differential release between AIF and cytochrome c.
Smac/DIABLO and HtrA2/OMI: more than just IAP antagonists
The regulation of caspases occurs at the level of their activation, which requires dimerization in the case of apical caspases (caspase-8 and -9), and proteolysis in the case of the executioner caspases-3, -6 and -7 (Boatright et al., 2003) . Once activated, the catalytic activity of caspases is subject to direct inhibition. Members of the IAP protein family can counteract both the activation and the activity of caspases. IAPs are characterized by the presence of one or more baculoviral IAP repeat (BIR) domains, an evolutionarily conserved motif of 70-100 amino-acid residues, and often a C-terminal RING domain (Salvesen and Duckett, 2002) . XIAP, cIAP1, cIAP2 and NAIP can obstruct cell death by inhibiting caspase-3 and -7 activity. In addition, XIAP blocks both caspase-9 activation and activity. It is important to notice that from all IAP proteins, XIAP is the most efficient caspase inhibitor, with K i values ranging from 2 Â 10 À10 for caspase-7 to 1 Â 10 À9 for caspase-9, whereas cIAP-1, cIAP-2 and NIAP caspase inhibitory values are 10-to 100-fold lower (Salvesen and Duckett, 2002) . The RING domain of XIAP, cIAP1 and cIAP2 displays ubiquitin ligase activity, which allows it to target proteins for proteasomal destruction. Target proteins include caspase-3 and Smac/DIABLO (see below), but also XIAP, cIAP1 and cIAP2 themselves (Yang et al., 2000; Suzuki et al., 2001b) . Therefore, it is unclear to what extent the RING domain contributes to the antiapoptotic nature of IAPs.
Crystal structure analysis has revealed that inhibition of active caspase-3 and -7 by XIAP is brought about by direct binding of the linker region between BIR1 and BIR2 proximal to the BIR2 domain with the caspase catalytic site Huang et al., 2001; Riedl et al., 2001) . The BIR2 domain contributes to this binding by forcing the linker region in a conformation that is able to bind the active site of caspase-3 and -7. In the case of caspase-9 inhibition by XIAP, the inhibitory mechanism differs in two respects from the way active caspase-3 and -7 are hindered. First, the BIR3 domain of XIAP binds to caspase-9 . Second, the major caspase-9-BIR3 interaction site overlaps with the site that is used by caspase-9 for homodimerization (Shiozaki et al., 2003) . Since caspase-9 homodimerization is a prerequisite for its activation , the sequestration of caspase-9 into an inactive monomeric state by XIAP precludes the assembly of functional caspase-9. How do cells overcome the barrier imposed by IAPs to prevent caspase activation? As it happens, IAPs in turn are antagonized by proapoptotic IAP-binding proteins. These proteins include Hid, Grim, Reaper, Sickle and Jafrac2 in Drosophila, and at least two mitochondrial proteins in mammals, Smac/DIABLO and HtrA2/OMI. All IAPbinding proteins share a conserved four-residue IAPbinding motif (IBM) at their N-terminus that allows them to bind IAPs (Table 1) . Whereas the proapoptotic activity of Hid, Grim, Reaper and Sickle is mainly regulated at the transcriptional level, in mammalian cells the IAP antagonistic mechanism is regulated by the release of Smac/DIABLO and OMI/Htra2 from the IMS into the cytosol. However, this release can also be subject to transcriptional regulation. Certain proapoptotic Bcl-2 family members are upregulated at the transcriptional level in response to a number of stress conditions such as genotoxic damage or growth factor depletion (Puthalakath et al., 2002) , thereby contributing to the release of Smac/DIABLO and HtrA2/OMI (Figure 2 ).
Smac/DIABLO
Smac was identified as a protein present in the detergent-solubilized membrane fraction of HeLa cells that could stimulate caspase-3 activation in cell extracts . Of note, DIABLO was described independently by the group of David Vaux as Smac's murine counterpart, after identification of Smac in pulldown experiments using Flag-tagged XIAP and 293T cell lysates (Verhagen et al., 2000) . Smac protein is expressed in most adult human tissues including the brain, heart, liver, lung and spleen. The expression of DIABLO in adult mouse tissues, however, seems to be confined to the heart, liver, kidney and testis, as revealed by Northern blot analysis (Verhagen et al., 2000) . Smac/DIABLO orthologues are only present in vertebrate species. Human Smac and mouse DIABLO are nuclear encoded and synthesized as precursor proteins of 239 and 237 amino-acid residues containing an N-terminal MLS. Upon mitochondrial import, the MLS is removed by proteolysis, exposing the IBM at the N-terminus of mature Smac/DIABLO, which is present as a dimer. Through this IBM (Ala-Val-Pro-Ile), Smac/DIABLO is able to bind XIAP, cIAP1, cIAP2 and survivin. One Smac/DIABLO dimer binds one XIAP molecule by both IBMs, one interacting with BIR2 and the other one with BIR3 (Huang et al., 2003) . Structural analysis has revealed that the four N-terminal amino acids of Smac tether to a hydrophobic surface groove on the BIR3 domain of XIAP (Liu et al., 2000; Wu et al., 2000) . The same BIR3 groove binds the IBM exposed at the N-terminus (Ala-Thr-Pro-Phe) of the small subunit of caspase-9 following its autocatalytic processing after Asp315 Shiozaki et al., 2003) . So, one way in which Smac/DIABLO promotes caspase activation is by displacing caspase-9 complexed with XIAP. This inhibitory function of Smac/DIABLO relies on its IBM and has been exploited to sensitize cancer cells for cytotoxic drug treatment. This resulted in the finding that intracellular delivery of peptides of 4-8 amino-acid residues corresponding to the N-terminus of mature Smac/DIABLO sensitizes human leukaemic and breast cancer cells to death induced by cytotoxic drugs, opening perspectives for combating cancer (Arnt et al., 2002; Jia et al., 2003) . Similarly, a heptapeptide representing the N-terminus of mature Smac/DIABLO fused with the protein-transduction domain of the HIV TAT protein was able to enhance the antitumour activity of TRAIL in a malignant glioma xenograft model in mice (Fulda et al., 2002) . The potent sensitizing nature of these peptides is somewhat surprising in view of recent crystal structure and mutational analysis of the caspase-9-BIR3 complex. Mutations in the BIR3 domain that still allow binding to caspase-9 through its IBM but destabilize the interface between caspase-9 and XIAP-BIR3 failed to inhibit caspase-9 activity (Shiozaki et al., 2003) . Furthermore, cleavage of caspase-9 by caspase-3 after Asp330 generates a new N-terminus, lacking an IBM, at the small subunit of caspase-9. Nevertheless, this form of caspase-9 can still be inhibited by XIAP (Zou et al., 2003) . If the IBMbinding site in XIAP is not absolutely required for its antiapoptotic activity, how do IBM-like peptides then act as IAP antagonists? As discussed above, the interaction between XIAP-BIR3 and caspase-9 involves multiple interaction sites. Possibly, the IBM-binding groove in the BIR3 domain of XIAP is an initial docking site for caspase-9 and cooperates with subsequent interaction sites between BIR3 and caspase-9. Saturation of the BIR3 groove with IBM-like peptides in a cellular context may sufficiently thwart XIAP recruitment to caspase-9 to allow full activation of the apoptosome. The mechanism by which Smac/DIABLO binds to the BIR2 domain of XIAP is unclear, although it requires the IBM and dimeric Smac/DIABLO Chai et al., 2001) . In contrast, the interaction of active caspase-3 and -7 with the BIR2 domain of XIAP does not involve a free N-terminus or IBM. How can Smac/ DIABLO alleviate XIAP-mediated caspase-3 and -7 inhibition? The answer seems to lie in the dimeric structure, and thus the bivalent nature of Smac/ DIABLO and the presence of multiple BIR domains in XIAP. Using in vitro binding and caspase activity assays, Huang et al. (2003) recently showed that Smac/ DIABLO interacts as a dimer with one XIAP molecule, by concurrently binding both BIR2 and BIR3 domains. This interaction occurs with subnanomolar dissociation constant (K D ), whereas the interaction of Smac/DIA-BLO with the BIR2 or BIR3 domain of XIAP individually takes place with micromolar K D . This is a nice example of avidity, the binding strength between two molecules determined by two or more sites of interaction. This strong affinity for XIAP allows Smac/DIABLO to displace caspase-7 (and caspase-9) from XIAP in vitro, thereby facilitating their activation.
IAPs, however, are able to fight back Smac/DIABLO in order to maintain an antiapoptotic state in the cell. The RING domain present in XIAP, cIAP1 and cIAP2 has been reported to posses ubiquitin-protein ligase activity, and may contribute to the antiapoptotic function of IAPs by targeting Smac/DIABLO for proteasome-mediated degradation (MacFarlane et al., 2002; Hu and Yang, 2003) . However, in thymocytes this activity turns against the IAPs, as cIAP1 and XIAP were found to be autoubiquitinated and degraded in response to glucocorticoid or etoposide treatment (Yang et al., 2000) . Smac3, a Smac splice variant that is also targeted to the mitochondria, contains an IBM and is released into the cytosol in response to apoptotic stimuli, was recently shown to bind to XIAP and to promote XIAP ubiquitination (Fu et al., 2003) .
At odds with this elegant Smac/DIABLO-IAP, antagonism is the proapoptotic nature of Smac b, a splice variant of Smac that lacks the mitochondrial targeting sequence and does not bind IAPs, yet sensitizes apoptosis induced by death ligands and chemical stimuli (Roberts et al., 2001) . The proapoptotic function of Smac b is performed by its C-terminal domain. The physiological mitochondrial function of Smac/DIABLO is unknown, and Diablo À/À mice are apparently normal. Although lysates from Diablo À/À cells did not show caspase-3 processing upon addition of cytochrome c, Diablo À/À mice and cells responded normally to apoptotic stimuli (Okada et al., 2002) . This observation suggests the existence of redundant factors compensating for the loss of Smac/DIABLO, possibly HtrA2/OMI (see below) or that Smac/DIABLO has no essential and general role in apoptosis during development.
HtrA2/OMI
HtrA2/OMI, first cloned as an Mxi2-interacting protein, is a ubiquitously expressed mitochondrial IMS serine protease that shares sequence and structural homology to Escherichia coli HtrA/DegP (Faccio et al., 2000; Gray et al., 2000; Clausen et al., 2002; Krojer et al., 2002; Li et al., 2002) . HtrA/DegP, localized in the bacterial periplasmic space, functions as a chaperone at normal temperatures and transforms into an active endoprotease that cleans up damaged and misfolded proteins at elevated temperatures (Spiess et al., 1999) . Therefore, HtrA/DegP plays a crucial role in bacterial thermo and oxidative tolerance (Lipinska et al., 1990; SkorkoGlonek et al., 1999) . Evidence for an HtrA/DegP-like function of HtrA2/OMI is supported by the upregulation of both its expression and proteolytic activity following heat shock (Gray et al., 2000; Martins et al., 2003) . Although the mitochondrial function of HtrA2/ OMI is still not well defined, a role for HtrA2/OMI in the maintenance of mitochondrial homeostasis has been suggested in motor neuron degeneration 2 (mnd2) mice (Jones et al., 2003) . In the mnd2 phenotype, muscle wasting, neurodegeneration and involution of the spleen and thymus, leading to juvenile death of the mice, are caused by a missense mutation in HtrA2/OMI. This mutation strongly impairs the proteolytic activity of HtrA2/OMI and correlates with a higher susceptibility of mnd2 MEFs to stress-inducing agents such as etoposide and tunicamycin, compared to wt MEFs. In addition, mitochondria from permeabilized mnd2 MEFs display increased mitochondrial depolarization in response to calcium pulsing.
The nuclear-encoded HtrA2/OMI is expressed as a 50 kDa precursor protein possessing an N-terminal MLS, which is removed upon mitochondrial import, followed by a second leader sequence containing a transmembrane domain. Processing of this second leader, which occurs in a subpopulation of the HtrA2/ OMI pool, exposes an IBM and generates mature 35 kDa HtrA2/OMI (Suzuki et al., 2001a; Hegde et al., 2002; Martins et al., 2002; van Loo et al., 2002b; Verhagen et al., 2002) . As catalytically inactive HtrA2/ OMI in mnd2 mice is correctly processed, maturation of HtrA2/OMI is probably catalyzed by other mitochondrial proteases (Jones et al., 2003) .
Apoptotic triggers that cause permeabilization of the OMM induce the release of HtrA2/OMI from the mitochondrial IMS into the cytosol, where it contributes to apoptosis in caspase-dependent and -independent ways. Similar to Smac/DIABLO, HtrA2/OMI competes with caspase-3, -7 and -9 for binding to XIAP, cIAP1 and cIAP2, thereby promoting caspase activity (Suzuki et al., 2001a; Hegde et al., 2002; Martins et al., 2002; van Loo et al., 2002b; Verhagen et al., 2002) . However, in contrast to Smac/DIABLO, which preferentially binds to the BIR3 domain of XIAP, HtrA2/OMI has a higher affinity for the BIR2 domain of XIAP (Verhagen et al., 2002) . Mutational analysis revealed that the binding of HtrA2/OMI to BIR3 is enhanced by changing A147 (the fourth amino-acid residue in the IBM of mouse HtrA2/ OMI) into Ile, as present in DIABLO (Verhagen et al., 2002) . Furthermore, following binding to its IBM, IAPs are cleaved by HtrA2/OMI, rendering them inactive Yang et al., 2003) . HtrA2/OMI is a trimer and therefore possesses three IBM motifs. Hence, it seems likely that avidity also contributes to the binding of HtrA2/OMI to IAPs. Besides its caspase-dependent cytotoxic activity, HtrA2/OMI also contributes to apoptosis in a caspase-independent way. This function is independent of its IAP-binding activity, but depends on the protease activity of HtrA2/OMI (Suzuki et al., 2001a; Hegde et al., 2002; Li et al., 2002; Verhagen et al., 2002; Vande Walle et al., unpublished results) .
The three-dimensional structure of HtrA2/OMI reveals the formation of a pyramid-shaped homotrimer, with the N-terminal IBMs on top, the serine protease domains in the centre and the PDZ domains at the bottom . The structure and deletion studies show that the C-terminal PDZ domain restricts access to the active site by packing against the protease domain, and as such exerts an inhibitory effect on the protease activity of HtrA2/OMI. PDZ domains (postsynaptic density protein, disc large tumour suppressor and Zo-1 tight junction protein), generally implicated in protein-protein interactions, can be subdivided into different classes based on their binding specificities (Harris and Lim, 2001; Hung and Sheng, 2002) . As the PDZ domain of HtrA2/OMI interacts with the Cterminus of Mxi2, its PDZ can be classified as a type II domain. This has been confirmed by screening a combinatorial peptide library for the preferred binding sequence of the PDZ domain of HtrA2/OMI (Martins et al., 2003) . Binding of peptides to the PDZ domain of HtrA2/OMI leads to a major increase in protease activity, again confirming the inhibitory role of the PDZ in HtrA2/OMI. Although HtrA2/OMI-deficient mice are not available yet, a contribution of HtrA2/OMI to apoptosis has been suggested by RNAi experiments, as cell death induced by Fas, TRAIL, staurosporine or UV is significantly reduced (Hegde et al., 2002; Martins et al., 2002) . In contrast, the mnd2 phenotype, attributed to impaired HtrA2/OMI catalytic activity, is characterized by an increased sensitivity to apoptotic triggers (Jones et al., 2003) . As downregulation of HtrA2/OMI expression levels or activity will influence both its mitochondrial function and its cytosolic role in cell death, it is impossible to make firm conclusions about the precise contribution of HtrA2/OMI to cell death as long as both functions cannot be uncoupled, for example by mutational intervention.
Other mitochondrial factors
The release of Smac and OMI along with cytochrome c upon OMM permeabilization indicates that the discharge mechanism for IMS proteins is not selective, and that 'innocent bystanders' may also find their way to the cytosol without overtly contributing to cell death.
Adenylate kinase 2 (AK2), which catalyses the reversible phosphorylation between nucleoside triphosphates and monophosphates, is an IMS protein that is released into the cytosol during apoptosis. However, its role in cell death, if any, remains elusive (Kohler et al., 1999) . To obtain insight into the repertoire of mitochondrial proteins that are released during apoptosis, we performed an in vitro reconstitution experiment using isolated mouse liver mitochondria challenged with a physiological concentration of tBid. The released proteins were identified using matrix-assisted laser desorption ionization postsource decay (MALDI-PSD) (van Loo et al., 2002) . In all, 16 proteins ranging in size from 10 to 123 kDa were identified, including cytochrome c, DIABLO, endonuclease G, Omi and AK2. To date, one can only speculate on the role of some of the other released mitochondrial proteins. Fatty acid-binding protein 1 (FABP1), one of the identified proteins released by tBid, binds free fatty acids as well as their CoA derivatives, and is implicated in intracellular lipid transport and metabolism (Glatz et al., 2002) . Whether FABP1 can act in concert with the lipid transferase activity of tBid is unknown (Esposti et al., 2001) . Another protein that was identified by the MALDI-PSD approach described above is polypyrimidine tractbinding (PTB) protein, an RNA-binding protein necessary for efficient translation of mRNAs containing an internal ribosomal entry site (IRES). Mitchell et al. (2001) demonstrated the involvement of PTB in the activation of the Apaf-1 IRES. A functional role in mitochondria-dependent cell death for released AcylCoA-binding protein (ACBP), a 20 kDa protein localized to the OMM, can be surmized from its potential to activate m-calpain (Melloni et al., 2000) . Calpain can proteolytically activate Bid, which may occur in vivo during reperfusion of the ischemic heart, as demonstrated using isolated rabbit hearts, and in the absence of caspase activity (Chen et al., 2001) . The release of ACBP from mitochondria could thus represent a positive feedback loop by stimulating calpain, which in turn cleaves Bid to generate a tBid-like fragment able to attack mitochondria. In certain cell types, the presence of procaspases (-2, -3, -8 and -9) in the IMS has been reported (Mancini et al., 1998; Samali et al., 1998; Susin et al., 1999a; Zhivotovsky et al., 1999; Qin et al., 2001) . The release of procaspases from the mitochondria, and their subsequent activation in the cytosol, could provide an elegant paradigm for the apoptogenic activity of mitochondrial factors liberated in the cytosol. However, we could not identify any procaspase or active caspase in the purified mitochondria from different cell types using immunoblot detection (van Loo et al., 2002a) . Moreover, except for procaspase-2, none of the caspases seems to contain an MLS, questioning the possibility that procaspases get into mitochondria.
Conclusions
Next to their major role in energy metabolism, mitochondria exert a role in apoptosis by releasing IMS proteins. Upon disruption of the OMM, a set of proteins is released, and these contribute to apoptosis in a caspase-dependent or -independent way. The release of cytochrome c that directly promotes caspase activation in addition to the liberation of proteins such as Smac/ DIABLO and HtrA2/OMI, which indirectly stimulate caspases by counteracting IAPs, especially XIAP, indicates that a dynamic equilibrium exists between pro-and antiapoptotic effector molecules. This interplay may allow the cell to cope with limited mitochondrial damage, in which case IAPs can adequately block caspase activation initiated by a small amount of released cytochrome c. In cases where mitochondrial damage proceeds or affects multiple mitochondria, the antiapoptotic hurdle imposed by IAPs can be overcome by the higher cytosolic concentration of their antagonists Smac/DIABLO and HtrA2/OMI, which neutralize IAPs by direct binding. The release of mitochondrial IMS proteins does not only provoke caspase-dependent mechanisms as endonuclease G and AIF but also Smac/ DIABLO and HtrA2/OMI exert caspase-independent cytotoxic activity. This caspase-independent function of mitochondrial IMS proteins has been inferred from their cytosolic overexpression, but the molecular mechanisms of these caspase-independent mitochondrial pathways are still not understood. Whether these or other mitochondrial proteins contribute to cell death that proceeds in the complete absence of caspase activity is unknown. Likewise, the release of mitochondrial proteins during necrosis (Denecker et al., 2001b; van Loo et al., 2002b) has not been observed, despite the important role of mitochondria in necrotic cell death (Fiers et al., 1999; Denecker et al., 2001a) . The release of mitochondrial IMS proteins has been reported in cell death with morphological characteristics of autophagy. Cell death associated with autophagy, a cellular turnover process that degrades macromolecules and organelles by targeting them to the lysosomes, can occur concurrent with mitochondrial OMM permeabilization in response to apoptotic stimuli, for example in neurons deprived of nerve growth factor (Xue et al., 1999) . Autophagy is primarily a life-saving cellular response, and may become active in parallel with mitochondrial dysfunction, or downstream of mitochondrial protein release. So far, no requirement for the release of mitochondrial proteins in autophagic cell death has been reported. Our lack of knowledge of caspase-independent cell death mechanisms used by mitochondrial or other proteins merits further research into this field. This may lead to the generation of novel small molecule inhibitors or activators of these pathways with therapeutic potential for the treatment of diseases associated with massive cell death or cancer.
